CN107441403A - 一种治疗产后抑郁的中药方剂 - Google Patents
一种治疗产后抑郁的中药方剂 Download PDFInfo
- Publication number
- CN107441403A CN107441403A CN201610367382.0A CN201610367382A CN107441403A CN 107441403 A CN107441403 A CN 107441403A CN 201610367382 A CN201610367382 A CN 201610367382A CN 107441403 A CN107441403 A CN 107441403A
- Authority
- CN
- China
- Prior art keywords
- parts
- postpartum depression
- lily
- chinese medicinal
- jujube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000009916 Postpartum depression Diseases 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 28
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 22
- 235000021307 Triticum Nutrition 0.000 claims abstract description 22
- 235000018958 Gardenia augusta Nutrition 0.000 claims abstract description 21
- 241000234435 Lilium Species 0.000 claims abstract description 21
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 20
- 235000004347 Perilla Nutrition 0.000 claims abstract description 20
- 240000004307 Citrus medica Species 0.000 claims abstract description 19
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 19
- 235000001938 Citrus medica Nutrition 0.000 claims abstract description 18
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims abstract description 18
- 241000220317 Rosa Species 0.000 claims abstract description 18
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 17
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 17
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 17
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 4
- 241000209140 Triticum Species 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 18
- 229940079593 drug Drugs 0.000 abstract description 7
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 244000098338 Triticum aestivum Species 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 description 17
- 230000006870 function Effects 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 11
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 206010038743 Restlessness Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000001431 Psychomotor Agitation Diseases 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 5
- 230000036651 mood Effects 0.000 description 5
- 230000007958 sleep Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000001671 psychotherapy Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- NXJCRELRQHZBQA-UHFFFAOYSA-N 5,7-dimethoxy-1-benzopyran-2-one Chemical compound C1=CC(=O)OC2=CC(OC)=CC(OC)=C21 NXJCRELRQHZBQA-UHFFFAOYSA-N 0.000 description 2
- MQBFFYQCZCKSBX-UHFFFAOYSA-N 5-hydroxy-6,7,8-trimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=C(OC)C(OC)=C(OC)C(O)=C3C(=O)C=2)=C1 MQBFFYQCZCKSBX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- -1 amaroid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- KUBCEEMXQZUPDQ-UHFFFAOYSA-N hordenine Chemical compound CN(C)CCC1=CC=C(O)C=C1 KUBCEEMXQZUPDQ-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 description 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 229930188400 Gardenin Natural products 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 244000003342 Lilium longiflorum Species 0.000 description 1
- 235000005356 Lilium longiflorum Nutrition 0.000 description 1
- 241001359444 Lilium tenuifolium Species 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 240000006066 Rosa rugosa Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042464 Suicide attempt Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000020127 ayran Nutrition 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001653 citalopram Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960004038 fluvoxamine Drugs 0.000 description 1
- CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940071490 hordenine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 229940035613 prozac Drugs 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000000697 serotonin reuptake Effects 0.000 description 1
- 229960002073 sertraline Drugs 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000009396 suanzaoren Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗产后抑郁的中药方剂,涉及中药领域。其由含有下述重量配比的原料药制备而成:紫苏叶,百合,玫瑰花,炙甘草,淮小麦,大枣,栀子,淡豆豉,酸枣仁,佛手,生麦芽。本发明方剂具有疏肝解郁,养心安神的作用,适合用于治疗产后抑郁,疗效显著、见效快,无明显副作用。
Description
技术领域
本发明涉及中药领域,为一种治疗产后抑郁的中药方剂。
背景技术
抑郁症是一类严重损害人类身心健康的常见精神疾病,主要表现为情绪的持久低落,兴趣的丧失,思维迟钝,意志行为减少,严重者伴有自杀观念和行为,部分抑郁症患者会出现幻觉和妄想。当前世界十大疾病中,抑郁症名列第五位,其患病率已经超过了人们认为很常见的冠心病。而且,预计到2020年将跃升到第二位。抑郁症在女性中的患病率是男性的2倍。青春期、绝经期、产后都是妇女发生抑郁症的高危时期。
产后抑郁症是指发生于产褥期的抑郁,属于产后精神障碍的一种。主要临床症状有:抑郁、悲伤、沮丧、哭泣、失眠,易激惹烦躁,重者出现幻觉、自残、自杀甚至杀婴。患者对日常活动缺乏兴趣,对各种娱乐体验不到愉快,常常自卑、自责、内疚。对生活失去信心,自认为前途暗淡,毫无希望,感到生活没有意义,甚至企图自杀;很难专心致志地工作,尽管他们可能有远大理想和抱负,但很少脚踏实地去做。约80%的病例,以失眠、头痛、身痛、头昏、眼花、耳鸣等躯体症状为主向医生求助。产后抑郁症通常在6周内发病,可在3~6个月自行恢复,但严重的也可持续1~2年。
针对产后抑郁症主要有以下机种治疗方法:1.心理治疗,支持性心理治疗、人际心理治疗、音乐疗法、焦点转移、行为调整法等,是在用药物治疗的同时,配合心理治疗主要是用来改变不适当的认知或思考习惯,或行为习惯,是一种辅助的治疗方法。2.常规治疗失眠抑郁患者可用药物加心理联合治疗。3.西医药物治疗可选用选择性5-羟色胺再摄取抑制,代表药物有氟西汀、帕罗西汀、舍曲林、氟伏沙明、西酞普兰。4.其他方法:多接受阳光与运动对于抑郁症病人有有利的作用;多活动活动身体,可使心情得到意想不到的放松作用;阳光中的紫外线可或多或少改善一个人的心情.好的生活习惯,规律与安定的生活是抑郁症患者最需要的,早睡早起,保持身心愉快,以愉悦的心情面对每一天,凡事都要抱着积极乐观的态度,期以增加个人生命的色彩与亮度。中医中药在抗抑郁方面,有不错的疗效。
从中医体质学角度来看,气郁体质是抑郁症的高发人群,气郁体质的人发生产后抑郁的机率远高于常人。体质是人体在遗传性和获得性的基础上表现出来的功能和形态上相对稳定的固有特性,但同时体质也是可调的。中医体质学说时里的体病相关理论就讲到可通过对体质的调理和干预来达到治疗相关疾病的目的。
产后抑郁目前临床仍以药物治疗为主,其他支持性疗法为辅,但治疗抑郁的西药易产生药物依赖性及其他副作用,尤其对于产后处于哺乳期妇女,还会影响新生儿的健康。因此临床上急需疗效明确,使用安全,不影响哺乳及新生健康的纯中药制剂。
发明内容
本项发明发明人经多年临床认为,产后抑郁为气郁体质的典型表现,可以借用中医体质学说时里的体病相关理论,采用专方进行调节。发明人总结多年经验,提供了一种专门应用于治疗产后抑郁的中药方剂,具有疗效确切,组方精炼安全,不影响哺乳及新生健康,并专程针对于女性抑郁人群的口感进行组方设计以增强其服用的依从性,适合中药新药及食品开发的特点。
本发明采用的技术方案是:
一种治疗产后抑郁的中药方剂,其特征是由以下重量份的中药制成:
紫苏叶5-15份,百合10-30份,玫瑰花5-15份,炙甘草5-15份,淮小麦10-30份,大枣5-15份,栀子5-15份,淡豆豉3-10份,酸枣仁5-20份,佛手5-15份,生麦芽5-20份。
作为优选项:
所述中药原料重量份构成如下:紫苏叶6-12份,百合15-25份,玫瑰花6-12份,炙甘草6-12份,淮小麦15-30份,大枣6-12份,栀子6-12份,淡豆豉5-10份,酸枣仁10-20份,佛手6-12份,生麦芽10-20份。
再优选所述中药原料重量份构成为:紫苏叶9份,百合20份,玫瑰花10份,炙甘草10份,淮小麦20份,大枣10份,栀子10份,淡豆豉6份,酸枣仁15份,佛手10份,生麦芽15份。
本发明所述中药方剂的功能主治为:疏肝解郁,养心安神。主要用于治疗气郁体质引起的产后抑郁合并失眠。其组方方解即作用机理为:
抑郁是气郁体质的典型表现,其多由忧思郁怒、精神苦闷导致气血郁结,肝脾瘀滞,久郁化热,烦躁难眠。常感情绪低沉,焦虑不安,善太息,易失眠等。
本方由张仲景《金匮要略》甘麦大枣汤和酸枣仁汤、《伤寒论》的栀子豉汤化裁而来。方中紫苏叶疏肝解郁、宽胸下气,百合甘寒,可清心安神,紫苏叶配百合,形成引阳入阴、专主失眠之药对,取百合朝开暮合,紫苏叶朝仰慕垂之意,共为君药。玫瑰花解郁安神,生麦芽疏肝解郁,佛手能疏肝解郁,理气而不伤阴;酸枣仁养心安神;上述四药共为臣药。山栀清心泻火除火郁;淡豆豉升散调中,与臣药栀子配伍,形成栀子豉汤,泄热除烦,降中有宣,宣中有降。小麦养心阴,益心气,安心神,除烦热;均为佐药。大枣益气和中,润燥缓急;甘草补益心气,和中缓急,为方中使药,其与小麦、大枣合成甘麦大枣汤,甘润平补、养心调肝,使心气充,阴液足,肝气和。诸药合用,诸气得畅,诸郁得解,诸烦得散,诸神得安,失眠自止。
组方中各配伍中药的药理作用阐述如下:
紫苏叶:为唇形科植物紫苏Perilla frutescens(L.)Britt的干燥叶(或带嫩枝)。味辛,性温。归肺、脾经。功能解表散寒,行气和胃。含有挥发油,内主要含紫苏醛和左旋柠檬烯及α-蒎烯少量。还含精氨酸、枯酸、矢车菊素3-(6-对香豆酰-β-D-葡萄糖甙)5-β-D-葡萄糖甙。实验证明有解热、抗菌和降糖作用。临床用于风寒感冒,咳嗽呕恶,妊娠呕吐,鱼蟹中毒。
百合:为百合科植物百合、细叶百合、麝香百合及其同属多种植物鳞茎的鳞叶。味甘、微苦,性平。入心、肺经。具有润肺止咳、清心安神的功效。临床主治肺痨久嗽、咳唾痰血、热病后余热未清、虚烦惊悸、神志恍惚、脚气浮肿等。现代研究主要成分有秋水仙碱等多种生物碱及淀粉、蛋白质、脂肪、双磷脂酰甘油和磷脂肪酸等。药理证实具有止咳、祛痰、平喘、升高外周白细胞及抗过敏作用。
玫瑰花:为蔷薇科植物玫瑰Rosa rugosa Thunb.的干燥花蕾。甘、微苦,温。归肝、脾经。功能行气解郁,和血,止痛。用于肝胃气痛,食少呕恶,月经不调,跌扑伤痛。含有挥发油、槲皮甙、苦味质、鞣质、脂肪油、有机酸(没食子酸)、红色素、黄色素、蜡质、β-胡萝卜素等。挥发油的主要成分有主要成分为香茅醇、牻牛儿醇、橙花醇、丁香油酚、苯乙醇等。
甘草:为豆科植物甘草.胀果甘草和光果甘草的干燥根及根茎。其中炙甘草为取甘草片,照蜜炙法炒至黄色至深黄色,不粘手时取出,晾凉。味甘,性平。入心、肺、脾、胃经。具有补脾益气、和中缓急、润肺、解毒、调和诸药的功效。临床主治咽喉肿痛、消化性溃疡、痈疽疮疡,解药毒及食物中毒等。现代研究甘草主要含三萜类、黄酮类、生物碱类和多糖类物质。药理证实具有抗炎、抗过敏、解毒、解热镇痛、镇咳及肾上腺皮质激素样作用等作用。
小麦:为禾本科植物小麦的种子。味甘;性凉,归心、脾、肾经。功能养心;益肾;除热;止渴。主脏躁;烦热;消渴;泄利;痈肿;外伤出血;烫伤。
大枣:为鼠李科枣属植物枣的干燥成熟果实。味甘性温,归脾、胃经。功能补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。
栀子:为茜草科植物栀子Gardenia jasminoides Ellis的干燥成熟果实。味苦,性寒。归心、肺、三焦经。功能果实:泻火除烦,清热利尿,凉血解毒。含有含黄酮类栀子素、果胶、鞣质、藏红花素、藏红花酸、D-甘露醇、廿九烷、β-谷甾醇等。药理研究证明有利胆、镇静、降压、抗微生物等作用。临床常用于热病心烦,黄疸尿赤,血淋涩痛,血热吐衄,目赤肿痛,火毒疮疡;外治扭挫伤痛。
淡豆豉:为豆科植物大豆Glycine max(L.)Merr.的成熟种子的发酵加工品。苦、辛,凉。归肺、胃经。功能解表,除烦,宣发郁热。用于感冒、寒热头痛,烦燥胸闷,虚烦不眠。
酸枣仁:为鼠李科植物酸枣的干燥成熟种子。甘、酸,平。归肝、胆、心经。功能养心补肝,宁心安神,敛汗,生津。用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴。酸枣仁含有脂肪油,蛋白质,生物碱,三萜皂苷,黄酮类化合物,氨基酸,甾醇,维生素C和多种微量元素。多种实验证明其有镇静催眠,强心抗心肌缺血,抗氧化,增强免疫等多种作用。
佛手:为芸香科柑橘属植物佛手Citrus medica L.var.sarcodactylis Swingle的干燥果实。辛、苦、酸,性温。归肝、脾、肺经。功能舒肝理气,和胃止痛。含有柠檬油素,6,7-二甲氧基香豆精,3,5,8-三羟基-4′,7-二甲氧基黄酮,柠檬苦素,胡萝卜甙,β-谷甾醇,对-羟基苯丙烯酸,棕榈酸,琥珀酸等。药理实验证明有抗炎、平喘、祛痰、抗心肌缺血、抑制消化道平滑肌痉挛等作用。临床常用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐等。
麦芽:为禾本科植物大麦Hordeum vulgare L.的成熟果实经发芽干燥而得。将麦粒用水浸泡后,保持适宜温、湿度,待幼芽长至约0.5cm时,晒干或低温干燥。麦芽有生麦芽,炒麦芽和焦麦芽。本发明用生麦芽。味甘性平,归脾、胃经。麦芽含有d-及β-淀粉酶,催化酶,过氧化异构酶等。另含大麦芽碱,大麦芽胍碱A、B,腺嘌呤,胆碱,蛋白质,氨基酸,维生素D、D、E,细胞色素C等。功能行气消食,健脾开胃,退乳消胀。用于食积不消,脘腹胀痛,脾虚食少,乳汁郁积,乳房胀痛,妇女断乳。
临床研究
本发明对临床78例病例验证使用,以本发明方剂为基本方加减治疗产后抑郁,大部分患者在服药一周后,症状减轻;用药1个月,;症状可以完全缓解。其中一月后治愈70例,占89.7%;好转6例,占7.7%;无效2例,占2.7%%;有效率达97.4%。所有病例未见不良反应。
典型临床病例
病例1:
王某,女,32岁。2010年10月以失眠就诊。主诉:生产一月后睡眠差,偶有头疼,导致有时精神恍惚,焦躁易怒,莫名发脾气。近一月有加重迹象。经询问,患者对什么都缺失兴趣,常有莫名担心。诊断为气郁体质发生的产后抑郁。给予服用本发明实施例1组合。一周后复诊睡眠状况改善。再服14天,睡眠好,精神佳,无莫名发脾气情况。再服一周巩固疗效。随访1年无复发。
病例2:
刘某,女,34岁。2011年7月以头疼失眠就诊。主诉:产后一月后,常头疼,入睡困难,感觉视物吃力。近一月常无故生气发脾气,自觉常感思路不清,困顿乏力。诊断为气郁体质发生的产后抑郁。以本发明实施例6组合,先服一周。再诊自觉症状明显减轻。效不更方,再服14剂。复诊头疼不再,睡眠可,精神佳,前症若失。再服7剂固效。后随访1年,未复发。
病例3:
柳某,女,30岁。主诉:产后一月后,常无故发脾气,入睡困难,情绪低落,近期常觉头疼,周身痛。诊断为气郁体质发生的产后抑郁。给予本发明实施例9组合7剂。再诊自觉症状明显减轻。效不更方,再服14剂。复诊头疼不再,睡眠可,精神佳,前症若失。再服7剂固效。后随访1年,未复发。
综上所述本发明所述方剂对产后抑郁症安全有效,非常适合开发成中药制剂。
具体实施方式
以下结合实施例对本发明作进一步的说明。
实施例1
紫苏叶9份,百合20份,玫瑰花10份,炙甘草10份,淮小麦20份,大枣10份,栀子10份,淡豆豉6份,酸枣仁15份,佛手10份,生麦芽15份。
制备步骤:
将所称取的各味中药,按传统工艺煎成汤剂或按常规的中成药制剂工艺加工成中国药典中所定义的片剂、丸剂、胶囊、颗粒剂、散剂或口服液等临床主要中成药制剂或依照常规食品加工工艺制成食品。
实施例2
称取紫苏叶15份,百合30份,玫瑰花5份,炙甘草5份,淮小麦30份,大枣15份,栀子5份,淡豆豉10份,酸枣仁5份,佛手5份,生麦芽20份。
制备步骤同实施例1。
实施例3
称取紫苏叶5份,百合10份,玫瑰花15份,炙甘草15份,淮小麦10份,大枣5份,栀子15份,淡豆豉3份,酸枣仁20份,佛手15份,生麦芽5份。
制备步骤同实施例1。
实施例4
称取紫苏叶6份,百合12份,玫瑰花9份,炙甘草12份,淮小麦25份,大枣9份,栀子12份,淡豆豉5份,酸枣仁9份,佛手12份,生麦芽9份。
制备步骤同实施例1。
实施例5
称取紫苏叶9份,百合15份,玫瑰花12份,炙甘草9份,淮小麦15份,大枣12份,栀子6份,淡豆豉9份,酸枣仁12份,佛手9份,生麦芽12份。
制备步骤同实施例1。
实施例6
称取紫苏叶9份,百合25份,玫瑰花15份,炙甘草15份,淮小麦15份,大枣12份,栀子12份,淡豆豉9份,酸枣仁15份,佛手12份,生麦芽15份。
制备步骤同实施例1。
实施例7
称取紫苏叶12份,百合18份,玫瑰花6份,炙甘草6份,淮小麦20份,大枣10份,栀子10份,淡豆豉6份,酸枣仁18份,佛手6份,生麦芽18份。
制备步骤同实施例1。
实施例8
称取紫苏叶12份,百合10份,玫瑰花10份,炙甘草10份,淮小麦20份,大枣10份,栀子8份,淡豆豉10份,酸枣仁15份,佛手9份,生麦芽15份。
制备步骤同实施例1。
实施例9
称取紫苏叶9份,百合20份,玫瑰花10份,炙甘草9份,淮小麦20份,大枣10份,栀子9份,淡豆豉6份,酸枣仁10份,佛手10份,生麦芽20份。
以上内容仅仅是对本发明如何实施所作的举例说明,而非本发明的保护范围,所属本技术领域的技术人员对所描述的具体实施例做的各种修改或补充或采用类似的方式替代,只要不偏离发明的结构或超越本权利要求书所定义的范围,均应属于本发明的保护范围。
Claims (4)
1.一种治疗产后抑郁的中药方剂,其特征是由以下重量份的中药制成:
紫苏叶5-15份,百合10-30份,玫瑰花5-15份,炙甘草5-15份,淮小麦10-30份,大枣5-15份,栀子5-15份,淡豆豉3-10份,酸枣仁5-20份,佛手5-15份,生麦芽5-20份。
2.根据权利要求1所述的治疗产后抑郁的中药方剂,其特征是由以下重量份的中药制成:
紫苏叶6-12份,百合15-25份,玫瑰花6-12份,炙甘草6-12份,淮小麦15-30份,大枣6-12份,栀子6-12份,淡豆豉5-10份,酸枣仁10-20份,佛手6-12份,生麦芽10-20份。
3.根据权利要求1所述的治疗产后抑郁的中药方剂,其特征是由以下重量份的中药制成:
紫苏叶9份,百合20份,玫瑰花10份,炙甘草10份,淮小麦20份,大枣10份,栀子10份,淡豆豉6份,酸枣仁15份,佛手10份,生麦芽15份。
4.根据权利要求1所述的治疗产后抑郁的中药方剂在用于制备药品及食品主要制剂中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610367382.0A CN107441403A (zh) | 2016-05-30 | 2016-05-30 | 一种治疗产后抑郁的中药方剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610367382.0A CN107441403A (zh) | 2016-05-30 | 2016-05-30 | 一种治疗产后抑郁的中药方剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107441403A true CN107441403A (zh) | 2017-12-08 |
Family
ID=60484766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610367382.0A Pending CN107441403A (zh) | 2016-05-30 | 2016-05-30 | 一种治疗产后抑郁的中药方剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107441403A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110772595A (zh) * | 2019-11-18 | 2020-02-11 | 黄泽昊 | 一种药食同源组合物及其制备方法和应用 |
CN111135271A (zh) * | 2018-11-05 | 2020-05-12 | 王停 | 一种治疗气郁引起的抑郁合并失眠的中药方剂 |
CN113274463A (zh) * | 2021-06-07 | 2021-08-20 | 邵阳学院 | 一种百合提取物抗抑郁组合物 |
CN114568707A (zh) * | 2022-03-16 | 2022-06-03 | 齐鲁工业大学 | 一种适用于抑郁易感人群的蛋白能量棒 |
CN116808153A (zh) * | 2023-06-30 | 2023-09-29 | 重庆五材堂健康管理有限公司 | 一种栀子鼓汤复合冲剂、制备方法及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412720A (zh) * | 2016-01-13 | 2016-03-23 | 辽宁中医药大学 | 一种用于气郁体质的药食配方 |
CN111135271A (zh) * | 2018-11-05 | 2020-05-12 | 王停 | 一种治疗气郁引起的抑郁合并失眠的中药方剂 |
-
2016
- 2016-05-30 CN CN201610367382.0A patent/CN107441403A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412720A (zh) * | 2016-01-13 | 2016-03-23 | 辽宁中医药大学 | 一种用于气郁体质的药食配方 |
CN111135271A (zh) * | 2018-11-05 | 2020-05-12 | 王停 | 一种治疗气郁引起的抑郁合并失眠的中药方剂 |
Non-Patent Citations (1)
Title |
---|
刘晶晶: "《新妈妈最想要的产后恢复全书》", 31 January 2014, 新时代出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111135271A (zh) * | 2018-11-05 | 2020-05-12 | 王停 | 一种治疗气郁引起的抑郁合并失眠的中药方剂 |
CN110772595A (zh) * | 2019-11-18 | 2020-02-11 | 黄泽昊 | 一种药食同源组合物及其制备方法和应用 |
CN113274463A (zh) * | 2021-06-07 | 2021-08-20 | 邵阳学院 | 一种百合提取物抗抑郁组合物 |
CN114568707A (zh) * | 2022-03-16 | 2022-06-03 | 齐鲁工业大学 | 一种适用于抑郁易感人群的蛋白能量棒 |
CN116808153A (zh) * | 2023-06-30 | 2023-09-29 | 重庆五材堂健康管理有限公司 | 一种栀子鼓汤复合冲剂、制备方法及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198236B (zh) | 一种治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
CN107441403A (zh) | 一种治疗产后抑郁的中药方剂 | |
CN101549101B (zh) | 一种用于治疗尘肺病和耐药性肺结核病的中药及制备方法 | |
CN107308097A (zh) | 一种化妆组成物 | |
CN103977281A (zh) | 一种治疗女性内分泌失调的中药组合物及其制备方法 | |
CN104189819B (zh) | 一种用于调理情绪健康的中药制剂 | |
CN102579818B (zh) | 一种藏药组合物及其制备方法与应用 | |
CN103028047B (zh) | 一种治疗慢性咽喉炎的中成药 | |
CN109420089A (zh) | 一种用于乳腺增生调理和预防的中药方剂 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN103202964B (zh) | 益脑安神药酒 | |
CN112915148A (zh) | 一种治疗阳痿、早泄及性功能障碍的中药组合物 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN109420115A (zh) | 一种用于女性更年期综合征调理的中药方剂 | |
CN104606542B (zh) | 一种含玛咖的中药组合物及其制备方法和应用 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
CN115006492B (zh) | 一种治疗失眠的中药组合物及其应用 | |
CN105944036A (zh) | 一种用于辅助治疗抑郁症的中药组合物 | |
CN105796854A (zh) | 止咳平喘汤 | |
CN105381204A (zh) | 一种百草之王长寿药剂及其制备方法 | |
CN104208366A (zh) | 一种治疗肾虚髓亏证型脑鸣的中药药剂 | |
CN104940694A (zh) | 一种治疗抑郁症的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171208 |